Clinical Trial Update: Pyridorin in Diabetic Nephropathy [Phase 3]

View source ↗

Summary

A Phase 3 trial of Pyridorin for diabetic nephropathy was terminated, ending the study sponsored by NephroGenex, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Kidney Disease
• Diabetic Nephropathy

Drugs mentioned

• Pyridorin

Snippet

Sponsor: NephroGenex, Inc. | Conditions: Diabetic Nephropathy, Diabetic Kidney Disease | Phase 3 | Status: TERMINATED